Development of a core outcome set for medication review in older patients with multimorbidity and polypharmacy: a study protocol
Jean-Baptiste Beuscart,1 Olivia Dalleur,1 Benoit Boland,2 Stefanie Thevelin,1 Wilma Knol,3 Shane Cullinan,4 Claudio Schneider,5 Denis O’Mahony,6 Nicolas Rodondi,4,7 Anne Spinewine1,8 1Université catholique de Louvain, Louvain Drug Research Institute, Clinical Pharmacy Research...
Guardado en:
Autores principales: | Beuscart JB, Dalleur O, Boland B, Thevelin S, Knol W, Cullinan S, Schneider C, O'Mahony D, Rodondi N, Spinewine A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3545f6975a30466cb8aba934972796d3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Use of Lipid-Lowering Drugs and Associated Outcomes According to Health State Profiles in Hospitalized Older Patients
por: Franchi C, et al.
Publicado: (2021) -
Factors Associated with the Detection of Inappropriate Prescriptions in Older People: A Prospective Cohort
por: Núria Molist-Brunet, et al.
Publicado: (2021) -
Economic Evaluations of Interventions to Optimize Medication Use in Older Adults with Polypharmacy and Multimorbidity: A Systematic Review
por: Laberge M, et al.
Publicado: (2021) -
PROSPERO's systematic review protocols of traditional Chinese medicine for COVID-19: An overview
por: Haiyin Hu, et al.
Publicado: (2021) -
Rates, variability, and associated factors of polypharmacy in nursing home patients
por: Beloosesky Y, et al.
Publicado: (2013)